Article
Host sirtuin 2 as an immunotherapeutic target against tuberculosis
22 Jul 2020
Abstract excerpt
Mycobacterium tuberculosis ( Mtb ) employs plethora of mechanisms to hijack the host defence machinery for its successful survival, proliferation and persistence. Here, we show that Mtb upregulates one of the key epigenetic modulators, NAD+ dependent histone deacetylase Sirtuin 2 (SIRT2), which upon infection translocate to the nucleus and deacetylates histone H3K18, thus modulating the host transcriptome leading...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
